Please login to read the full article.
Scrip Regulatory Affairs
07 October 2011
Vibha Sharma
Please login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- US FDA says use of spilt predicates is inconsistent with 510(k) device programme
- EU Commission proposes clinical evidence requirements for all IVDs except lowest-risk
- Proposed new feature in future EU IVD Regulation: the classification rules
- GHTF consults on deleting "type examination" option from its revised conformity assessment guideline
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
